Breast Cancer Stage 2 and 3: Clinical Trials

1 trial for Breast Cancer Stage 2 and 3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Breast Cancer Stage 2 and 3: new trials by email Literature Review of Breast Cancer Stage 2 and 3 trials Research Report on Breast Cancer Stage 2 and 3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Fenofibrate, Placebo, Doxorubicin - Breast Cancer Stage 2 and 3
Phase 2CompletedTanta University442023-12-012025-08-19

Narrower conditions

Breast Neoplasms (1)  ·  Cardiotoxicity (1)

Broader conditions

Breast Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Heart Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Radiation Injuries (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Wounds and Injuries (1)

Interventions

Cyclophosphamide (1)  ·  Doxorubicin (1)  ·  Fenofibrate (1)

Sponsors

Tanta University (1)

Countries

Egypt (1)

Top investigators

Hagar Dewidar, Instructor (1)

Results publications

PMID 40459761